About Lyndra
Lyndra is a Healthcare company based in Cambridge (United States) founded in 2015. Innovates long-acting oral therapies to simplify patient medication regimens. It operates on a B2B model. Lyndra has raised $305.01 million across 15 funding rounds from investors including Gilead, Fujifilm and Sun Pharma. The company has 107 employees. Lyndra offers products and services including LYNX Platform. Its focus areas include Biotech, Drug Delivery, Long-Acting Oral and Therapeutics. Its legal entity is LYNDRA, INC. Its competitors include Kriya Therapeutics, Sana Biotechnology and PureTech Health; 3 of its 3 listed competitors have raised funding.
Company details
Lyndra Therapeutics focuses on creating the LYNX drug delivery platform, which enables weekly or monthly dosing of medications to reduce the burden of daily pills. The company conducts research in areas like CNS disorders and collaborates with partners for clinical advancements. Based in Massachusetts, USA, it aims to transform patient experiences through innovative oral therapies, including for schizophrenia and malaria, by licensing technology and advancing clinical trials.
- Headquarters Cambridge, United States
- Employees 107
- SectorsHealthcare
- Phone•••• ••••
- Website lyndra.com
- Social LinkedIn X
- Legal Name Lyndra, Inc.
- Total Equity Funding$305.01M (USD)
in 15 rounds
- Latest Funding Round$122.75M (USD), Series C
Dec 2023
- InvestorsGilead
& 22 more
- Employee Count107
Products & Services of Lyndra
Lyndra offers a comprehensive portfolio of products and services, including LYNX Platform.
Enables long-acting oral therapies for various health conditions.
Funding Insights of Lyndra
Lyndra has successfully raised a total of $305.01M across 15 strategic funding rounds. The most recent funding activity was a Series C round of $122.75 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $305.01M
- Total Rounds 15
- Last Round Series C — $122.75M
- First Round $23.08M
(Jun 2016)
- Investors Count 23
Latest 10 of 15 funding rounds of Lyndra with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2023 | $122.75M | Series C | – | Sarissa Capital Management | |
| May 2023 | $20.35M | Series C | – | Polaris Partners | – |
| Jun 2021 | $60.5M | Series C | – | AIG | |
| Mar 2020 | $1M | Grant | – | – | |
| Jul 2019 | $13M | Grant | – | – | |
| Jun 2019 | $3M | Grant | – | – | |
| Jan 2019 | $55.24M | Series B | – | Polaris Partners | |
| Jun 2018 | $18M | Grant | – | – | |
| Sep 2017 | $225,000 | Grant | – | – | |
| Jun 2017 | $4M | Grant | – | – |
23 investors in total: 22 institutional and 1 angel.
Investors in Lyndra
Lyndra has secured backing from 23 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Gilead, Fujifilm and Sun Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
US focused venture capital firm | polarispartners.com | Boston, United States | ||
Tech & Life Sciences focused early stage VC firm investing in North America | quarkventure.com | Vancouver, Canada | ||
| massgeneralbrighamventures.com | ||||
Long-term private equity investments in transformational opportunities are pursued. | invus.com | New York, United States | ||
| yonghuacapital.com.cn | ||||
VC and PE investments are directed toward multiple sectors. | Beijing, China | |||
VC firm investing in the US | suffolkequity.com | Cambridge, United States | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | sunpharma.com | Mumbai, India | |
Investment management firm providing capital services and financial statements. | 2012 | sarissacap.com | Greenwich, United States | |
AIG is recognized as a leading global insurance organization. | 1919 | aig.com | New York, United States |
Investor details for Lyndra
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lyndra
20 people are tracked at Lyndra (5 in leadership, 8 in board & advisors, 7 in team); the tracked headcount is 107.
| Name | Role | Group |
|---|---|---|
Patrick Boen | Vice President Clinical Development | Leadership |
Divya Krishnamurthy, Ph.D. | Senior Director, Workplace Operations And Safety | Leadership |
Michelle O'Connor | Associate Director, Analytical Research And Development | Leadership |
Colin Gardner | Co-Founder | Leadership |
Maureen Chlopik | Vice President | Leadership |
Catherine B. Reynolds | Chair | Board & advisors |
Amy Schulman | Executive Chair, Co-Founder | Board & advisors |
Kevin G. Guise | Board Member | Board & advisors |
Jillian Moo-Young | Board Member | Board & advisors |
Douglas Dachille | Board Member | Board & advisors |
Zafrira Avnur | Board Member | Board & advisors |
Robert Langer | Co-Founder & Board Member | Board & advisors |
Giovanni Traverso | Co-Founder & Board Member | Board & advisors |
Katherine Bergman | Scientist I | Team |
Kevin Scranton | Associate Clinical Data Scientist | Team |
Denise Austin | Medical Writing Operations Manager | Team |
Carmi Mandelkern | Manager, Intellectual Property And Portfolio | Team |
Jonathan Raber | Manufacture Engineer | Team |
Roman Lovell | Engineer I | Team |
Zhiyu Xia | Senior Scientist | Team |
Complete people profiles for Lyndra
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lyndra
3 dated milestones of Lyndra across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Lyndra is founded.
- Funding First funding round of $23.1M.
- Funding Latest funding round, Series C, of $122.7M.
Competitors of Lyndra
Lyndra has 3 listed competitors in our database, 3 of them funded. They include Kriya Therapeutics, Sana Biotechnology and PureTech Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kriyatherapeutics.com | 2012 | Redwood, United States | $930.93M | 159 | Developer of therapeutic solutions for the treatment of diabetes | |
| sana.com | 2018 | Seattle, United States | $821M | 328 | Genetically engineered cell therapies are developed for multiple disorders. | |
| puretechhealth.com | 2001 | Boston, United States | $107M | 171 | Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases. |
Detailed competitors of Lyndra
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Lyndra
Websites that share an audience with Lyndra (lyndra.com).
Websites whose visitors overlap most with Lyndra. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| themedicinemaker.com | 100% | 8.1K | #2,851,127 | View details | |
| cuebiopharma.com | 97% | 4.9K | #7,063,180 | View details | |
| chromamedicine.com | 96% | View details | |||
| compasstherapeutics.com | 95% | 8.7K | #3,518,435 | View details | |
| sherlock.bio | 95% | 2.8K | #4,929,420 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 17 similar websites and full traffic analytics for Lyndra
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Lyndra (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lyndra
Complete news archive for Lyndra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lyndra
Lyndra was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Lyndra is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Lyndra is a funded company, having raised a total of $305.01M across 15 funding rounds to date. The company's 1st funding round was a Grant of $4M, raised on Jun 2016.
Lyndra has 107 employees.
Lyndra Therapeutics focuses on creating the LYNX drug delivery platform, which enables weekly or monthly dosing of medications to reduce the burden of daily pills. The company conducts research in areas like CNS disorders and collaborates with partners for clinical advancements. Based in Massachusetts, USA, it aims to transform patient experiences through innovative oral therapies, including for schizophrenia and malaria, by licensing technology and advancing clinical trials.
Lyndra's top competitors include Sana Biotechnology, PureTech Health and Kriya Therapeutics.
Lyndra offers LYNX Platform.
Lyndra has 23 investors. Key investors include Gilead, Fujifilm, Sun Pharma, NIH, and AIG.
Lyndra operates through Lyndra, Inc..